Full-Time

Lab Director

Posted on 9/11/2026

Valius Sciences

Valius Sciences

11-50 employees

Multi-omic cancer diagnostics with data platform

Compensation Overview

$200k - $300k/yr

+ Equity compensation + Refresh grants

Boston, MA, USA

In Person

PhD, MD

Category
Biology & Biotech

Get referred to Valius Sciences

See people who can refer or advise you

Requirements
  • An advanced degree (PhD, MD, or MD/PhD) in a relevant scientific discipline such as molecular biology, genomics, clinical laboratory science, or a related field.
  • A minimum of 8–10 years of experience in clinical laboratory operations.
  • A proven track record of establishing or scaling a molecular or clinical laboratory.
  • Experience overseeing development of advanced molecular diagnostic assays such as bulk RNA sequencing, whole exome sequencing, and/or spatial or single-cell RNA sequencing using a 10x Genomics platform.
  • The ability to recruit, develop, and retain scientific staff.
  • The ability to communicate complex laboratory data clearly and translate it into actionable information for clinical, scientific, and executive stakeholders.
Responsibilities
  • Lead the design, buildout, and commissioning of the laboratory, from physical space planning through instrument installation and workflow validation.
  • Define laboratory infrastructure requirements, including equipment, consumables, laboratory information management systems, and workflow automation, to support clinical-grade reproducibility and scale.
  • Establish and document standard operating procedures and training programs.
  • Direct day-to-day clinical laboratory operations, ensuring timely, accurate, and compliant processing of patient samples and reporting of results.
  • Oversee development and validation of complex molecular assays, including 10x Genomics spatial or single-cell RNA sequencing.
  • Manage technical transfer of assays from research and development into clinical operations.
  • Implement metrics for assay performance, turnaround time, and quality.
  • Recruit, train, and lead a team of clinical laboratory scientists, supervisors, and technologists.
  • Collaborate with computational biologists and translational scientists to integrate laboratory outputs into patient-facing reports.
  • Partner with bioinformatics and operations teams to ensure data integrity and compliant reporting of high-complexity results.
  • Contribute to scientific and operational strategy as a senior leader.
Desired Qualifications
  • Interest in working for a small, early-stage startup.

Valius Sciences develops precision oncology diagnostics that build detailed molecular profiles of tumors across DNA, RNA, and proteins to guide treatment choices. Its test combines multi-omic data and extensive gene expression analysis to identify actionable targets and cancer drivers that may be missed by standard tests. Rather than static PDFs, it offers a partnership model with an AI-queryable platform that stores all patient data and enables ongoing analysis and collaboration with Valius's scientific team. The goal is to help patients and clinicians prioritize effective therapies and plan for recurrence or progression through continuous, data-driven insights.

Company Size

11-50

Company Stage

Seed

Total Funding

$10M

Headquarters

San Francisco, California

Founded

2025

Get referred to Valius Sciences

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Valius raised $13.5 million on April 9, 2026, from 8VC and Basis Set.
  • The company now advertises active support for trial matching and single-patient INDs.
  • Valius says it is expanding clinical single-cell gene-expression analysis and its scientist team.

What critics are saying

  • Direct-pay pricing of $50,000-$90,000 kills routine adoption without reimbursement.
  • Tempus, Guardant Health, and Foundation Medicine already own oncologist workflows.
  • If payers or tumor boards reject maximalist reports, Valius loses referrals quickly.

What makes Valius Sciences unique

  • Valius sells DNA-RNA-protein tumor profiling, not single-layer sequencing.
  • It offers direct-pay, patient-facing interpretation plus ongoing scientific collaboration.
  • Its platform supports clinical trial matching, single-patient INDs, and recurrence monitoring.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Company Equity

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Valius Sciences
May 2nd, 2026
Valius Sciences – Valius raises $10M to build the future of cancer diagnostics

We're bringing maximalist diagnostics to more patients.

Legal Desire
Apr 27th, 2026
Valius Sciences raises $10M to develop cancer diagnostics

Valius Sciences, a San Francisco-based healthcare diagnostics company focused on cancer treatment, has raised more than $10 million in a Series Seed financing round. The round was led by 8VC and Basis Set Ventures. Sidley represented the company in the transaction.